NICOLE ANDERSON: Open Payments
NPI 1568092047 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 47 payments from 14 companies in 2025. Trend: 2023 $34 · 2024 $856 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $289 |
| Lilly USA, LLC | 6 | $117 |
| PFIZER INC. | 5 | $115 |
| Astellas Pharma US Inc | 4 | $103 |
| GlaxoSmithKline, LLC. | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Antares Pharma, Inc. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Dexcom, Inc. | 1 | $40 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
Products named: Wegovy, Veozah, MOUNJARO, Ozempic, JARDIANCE, NURTEC ODT, SHINGRIX, XYOSTED.
Industry payments across GA — which companies pay providers there.
